KRT18 and metabolic dysfunction-associated steatotic liver disease: In patients with or without NAFLD, the median FGF21 serum values were 387.2 versus 358.3 pg/mL (p = 0.1104); and for CK18, 0.7 versus 0.8 ng/mL (p = 0.7492).